Total Payments
$1,532
2024 Payments
$1,303
Companies
9
Transactions
12
Medicare Patients
4,673
Medicare Billing
$422,748
Payment Breakdown by Category
Consulting$1,200 (78.4%)
Food & Beverage$331.50 (21.6%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $1,200 | 2 | 78.4% |
| Food and Beverage | $331.50 | 10 | 21.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| BeiGene USA, Inc. | $675.00 | 1 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $569.15 | 2 | $0 (2024) |
| Seagen Inc. | $80.04 | 1 | $0 (2021) |
| SOBI, INC | $58.80 | 1 | $0 (2024) |
| Kite Pharma, Inc. | $36.06 | 2 | $0 (2023) |
| E.R. Squibb & Sons, L.L.C. | $34.30 | 2 | $0 (2022) |
| Tactile Systems Technology Inc | $33.19 | 1 | $0 (2023) |
| Celgene Corporation | $22.69 | 1 | $0 (2022) |
| Global Blood Therapeutics, Inc. | $22.27 | 1 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,303 | 4 | BeiGene USA, Inc. ($675.00) |
| 2023 | $69.25 | 3 | Kite Pharma, Inc. ($36.06) |
| 2022 | $56.99 | 3 | E.R. Squibb & Sons, L.L.C. ($34.30) |
| 2021 | $102.31 | 2 | Seagen Inc. ($80.04) |
All Payment Transactions
12 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/26/2024 | BeiGene USA, Inc. | BRUKINSA (Drug) | Consulting Fee | Cash or cash equivalent | $675.00 | General |
| Category: Oncology | ||||||
| 10/01/2024 | AstraZeneca Pharmaceuticals LP | IMFINZI (Biological) | Consulting Fee | Cash or cash equivalent | $525.00 | General |
| Category: Oncology | ||||||
| 09/26/2024 | SOBI, INC | VONJO (Drug) | Food and Beverage | In-kind items and services | $58.80 | General |
| Category: HEMATOLOGY/ONCOLOGY | ||||||
| 08/22/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $44.15 | General |
| 08/14/2023 | Tactile Systems Technology Inc | Flexitouch Plus (Device), Entre Plus | Food and Beverage | In-kind items and services | $33.19 | General |
| Category: PNEUMATIC COMPRESSOR | ||||||
| 07/18/2023 | Kite Pharma, Inc. | Yescarta (Drug) | Food and Beverage | In-kind items and services | $18.74 | General |
| Category: CELLT | ||||||
| 02/17/2023 | Kite Pharma, Inc. | — | Food and Beverage | In-kind items and services | $17.32 | General |
| 09/23/2022 | E.R. Squibb & Sons, L.L.C. | OPDIVO (Biological) | Food and Beverage | Cash or cash equivalent | $16.58 | General |
| Category: Oncology | ||||||
| 08/18/2022 | E.R. Squibb & Sons, L.L.C. | OPDIVO (Biological) | Food and Beverage | Cash or cash equivalent | $17.72 | General |
| Category: Oncology | ||||||
| 05/18/2022 | Celgene Corporation | REBLOZYL (Biological) | Food and Beverage | Cash or cash equivalent | $22.69 | General |
| Category: Hematology | ||||||
| 09/10/2021 | Global Blood Therapeutics, Inc. | OXBRYTA (Drug) | Food and Beverage | In-kind items and services | $22.27 | General |
| Category: SICKLE CELL DISEASE | ||||||
| 05/27/2021 | Seagen Inc. | ADCETRIS (Biological) | Food and Beverage | In-kind items and services | $80.04 | General |
| Category: Oncology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 36 | 2,338 | 4,721 | $845,848 | $195,407 |
| 2022 | 29 | 1,919 | 3,334 | $727,639 | $172,765 |
| 2021 | 9 | 416 | 613 | $192,295 | $54,577 |
Total Patients
4,673
Total Services
8,668
Medicare Billing
$422,748
Procedure Codes
74
All Medicare Procedures & Services
74 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 388 | 735 | $279,300 | $80,143 | 28.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 96 | 161 | $73,080 | $17,839 | 24.4% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 153 | 227 | $45,400 | $16,443 | 36.2% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 38 | 98 | $92,120 | $15,774 | 17.1% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 78 | 80 | $32,800 | $12,391 | 37.8% |
| 88185 | Flow cytometry technique for dna or cell analysis, each additional marker | Office | 2023 | 17 | 391 | $42,228 | $9,040 | 21.4% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 29 | 131 | $19,650 | $7,349 | 37.4% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 166 | 369 | $7,380 | $3,100 | 42.0% |
| 96413 | Administration of chemotherapy into vein, 1 hour or less | Office | 2023 | 11 | 24 | $13,200 | $3,096 | 23.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 31 | 39 | $11,700 | $2,928 | 25.0% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 135 | 268 | $16,080 | $2,767 | 17.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 18 | 18 | $10,710 | $2,725 | 25.4% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 161 | 340 | $51,000 | $2,587 | 5.1% |
| 82728 | Ferritin (blood protein) level | Office | 2023 | 72 | 131 | $19,650 | $1,750 | 8.9% |
| 83735 | Magnesium level | Office | 2023 | 104 | 212 | $15,900 | $1,393 | 8.8% |
| 83615 | Lactate dehydrogenase (enzyme) level | Office | 2023 | 114 | 222 | $6,660 | $1,314 | 19.7% |
| 96367 | Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less | Office | 2023 | 12 | 46 | $5,520 | $1,279 | 23.2% |
| 96365 | Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | Office | 2023 | 11 | 19 | $9,500 | $1,197 | 12.6% |
| 88184 | Flow cytometry technique for dna or cell analysis, first marker | Office | 2023 | 17 | 17 | $5,100 | $1,178 | 23.1% |
| 83550 | Iron binding capacity | Office | 2023 | 69 | 128 | $16,000 | $1,097 | 6.9% |
| 83521 | Measurement of immunoglobulin light chains | Office | 2023 | 24 | 60 | $4,200 | $1,016 | 24.2% |
| 84100 | Phosphate level | Office | 2023 | 103 | 212 | $10,600 | $985.80 | 9.3% |
| 82784 | Gammaglobulin (immune system protein) measurement | Office | 2023 | 28 | 108 | $4,860 | $984.24 | 20.3% |
| 83540 | Iron level | Office | 2023 | 72 | 131 | $9,170 | $830.54 | 9.1% |
| 82607 | Cyanocobalamin (vitamin b-12) level | Office | 2023 | 45 | 55 | $4,125 | $812.90 | 19.7% |
About Kevin Sing
Kevin Sing is a Hematology & Oncology healthcare provider based in Williamsburg, Virginia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/14/2015. The National Provider Identifier (NPI) number assigned to this provider is 1770979007.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Kevin Sing has received a total of $1,532 in payments from pharmaceutical and medical device companies, with $1,303 received in 2024. These payments were reported across 12 transactions from 9 companies. The most common payment nature is "Consulting Fee" ($1,200).
As a Medicare-enrolled provider, Sing has provided services to 4,673 Medicare beneficiaries, totaling 8,668 services with total Medicare billing of $422,748. Data is available for 3 years (2021–2023), covering 74 distinct procedure/service records.
Ad
Practice Information
- Specialty Hematology & Oncology
- Other Specialties Hematology & Oncology
- Location Williamsburg, VA
- Active Since 04/14/2015
- Last Updated 03/28/2025
- Taxonomy Code 207RH0003X
- Entity Type Individual
- NPI Number 1770979007
Products in Payments
- BRUKINSA (Drug) $675.00
- IMFINZI (Biological) $525.00
- ADCETRIS (Biological) $80.04
- VONJO (Drug) $58.80
- OPDIVO (Biological) $34.30
- Flexitouch Plus (Device) $33.19
- REBLOZYL (Biological) $22.69
- OXBRYTA (Drug) $22.27
- Yescarta (Drug) $18.74
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Hematology & Oncology Doctors in Williamsburg
Bo Zhao, Md, MD
Hematology & Oncology — Payments: $5,375
Hematology & Oncology $5,375
Ms. Angela Deridder, M.d, M.D
Hematology & Oncology — Payments: $2,836
Hematology & Oncology $2,836
John Miller, Md, MD
Hematology & Oncology — Payments: $1,172
Hematology & Oncology $1,172
Sonia Hepburn, M.d, M.D
Hematology & Oncology — Payments: $1,138
Hematology & Oncology $1,138
Christina Prillaman, Md Facp, MD FACP
Hematology & Oncology — Payments: $299.57
Hematology & Oncology $299.57